MEDIA CONTACTS media@galderma.com Christian Marcoux, Chief Communications Officer: +41 76 315 26 50 Sébastien Cros, Corporate Communications Director: +41 79 529 59 85 Filter news by date News Tags - Any -CampaignPress Releases Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year20222021202020192018201720162015201420132012201120102009200820072006 Apply 4 . 6 . 2022 Cetaphil® debuts global sensitive skin awareness initiative 4 . 4 . 2022 Galderma launches a virtual experience this Rosacea Awareness Month showcasing how the condition goes beyond the visible with Rosacea Space 3 . 28 . 2022 Galderma to present new clinical data and high patient satisfaction across their portfolio of dermal fillers, collagen biostimulators and liquid neuromodulators at AMWC 2022 3 . 25 . 2022 Galderma to highlight latest science and innovation across its product portfolio at the 2022 AAD Annual meeting 2 . 22 . 2022 Taro to acquire Alchemee from Galderma 2 . 18 . 2022 Karen L. Ling joins Galderma’s Advisory Committee 2 . 14 . 2022 Galderma launches Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology® designed to assist with recovery from surgical body procedures 1 . 5 . 2022 Galderma successfully completes acquisition of ALASTIN Skincare® 12 . 14 . 2021 Addressing gaps in acne management: New expert recommendations to optimize patient care 12 . 7 . 2021 Maria Teresa Hilado to join Galderma’s Advisory Committee 12 . 3 . 2021 Galderma announces new data demonstrating the positive anti-inflammatory effect and mode of action of nemolizumab in patients with moderate to severe Prurigo Nodularis 11 . 25 . 2021 Galderma to acquire award-winning ALASTIN Skincare® enhancing its integrated dermatology platform to continue delivering the best experience to patients 9 . 30 . 2021 RESTYLANE®, the original stabilized hyaluronic acid filler, celebrates 25 years of unmatched achievement Pagination Next page Next Page